Riddhiben Sachinkumar Gandhi

Riddhiben Sachinkumar Gandhi

Active Director Designated Partner DIN 07762052
DIN 07762052 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Riddhiben Sachinkumar Gandhi

Data last updated:

Riddhiben Sachinkumar Gandhi is a Designated Partner at Viezen Pharmaceutical Llp (since 2017). The company operates in Pharma.

DIN 07762052
Primary Designation Designated Partner
Industry Pharma
First Appointment 07 Apr 2017
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Apr 20172015Active

Board colleagues of Riddhiben Sachinkumar Gandhi

Directorship timeline

Open interactive timeline →
Viezen Pharmaceutical Llp
Premium access

Shareholding and investment profile for Riddhiben Sachinkumar Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riddhiben Sachinkumar Gandhi

Riddhiben Sachinkumar Gandhi currently holds 1 directorship: Viezen Pharmaceutical Llp (Designated Partner, since 07 Apr 2017).

Riddhiben Sachinkumar Gandhi was first appointed on 07 Apr 2017 as Designated Partner at Viezen Pharmaceutical Llp.

The current boards of Riddhiben Sachinkumar Gandhi's companies include Anjaliben Kunjalkumar Patel (Viezen Pharmaceutical Llp), Kinjalbahen Chandrahaskumar Vashi (Viezen Pharmaceutical Llp), Nirajkumar Mukeshkumar Patel (Viezen Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available